{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:53:10Z","timestamp":1791161590655,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.pain.2013.01.002","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T01:09:24Z","timestamp":1357952964000},"page":"700-707","source":"Crossref","is-referenced-by-count":69,"title":["The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats"],"prefix":"10.1097","volume":"154","author":[{"given":"Silke","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Doods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-12-20210126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pain.2007.01.024","article-title":"Spinal CGRP1 receptors contribute to supraspinally organized pain behavior and pain-related sensitization of amygdala neurons.","volume":"132","author":"Adwanikar","year":"2007","journal-title":"PAIN"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2009.09318.x","article-title":"Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis.","volume":"161","author":"Antunez","year":"2009","journal-title":"Br J Dermatol"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.035","article-title":"Calcitonin gene-related peptide and its role in migraine pathophysiology.","volume":"500","author":"Arulmani","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2009.00244.x","article-title":"Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats.","volume":"158","author":"Bernardi","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R25-12-20210126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-2-31","article-title":"Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP.","volume":"2","author":"Bird","year":"2006","journal-title":"Mol Pain"},{"key":"R30-12-20210126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neuropharm.2009.08.008","article-title":"Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.","volume":"58","author":"Boyce-Rustay","year":"2010","journal-title":"Neuropharmacology"},{"key":"R35-12-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cne.20669","article-title":"Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.","volume":"490","author":"Cottrell","year":"2005","journal-title":"J Comp Neurol"},{"key":"R40-12-20210126","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0333102410385585","article-title":"Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.","volume":"31","author":"Dodick","year":"2011","journal-title":"Cephalalgia"},{"key":"R45-12-20210126","first-page":"1261","article-title":"Development of CGRP antagonists for the treatment of migraine.","volume":"2","author":"Doods","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"R50-12-20210126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","article-title":"CGRP antagonists: unravelling the role of CGRP in migraine.","volume":"28","author":"Doods","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"R55-12-20210126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.","volume":"129","author":"Doods","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R60-12-20210126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1744-8069-8-61","article-title":"Spatiotemporal dynamics of re-innervation and hyperinnervation patterns by uninjured CGRP fibers in the rat foot sole epidermis after nerve injury.","volume":"8","author":"Duraku","year":"2012","journal-title":"Mol Pain"},{"key":"R65-12-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1527-3458.2005.tb00036.x","article-title":"Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks.","volume":"11","author":"Edvinsson","year":"2005","journal-title":"CNS Drug Rev"},{"key":"R70-12-20210126","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0304-3959(02)00208-7","article-title":"Phase I safety assessment of intrathecal ketorolac.","volume":"99","author":"Eisenach","year":"2002","journal-title":"PAIN"},{"key":"R75-12-20210126","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/ALN.0b013e3181d94dc0","article-title":"Role of spinal cyclooxygenase in human postoperative and chronic pain.","volume":"112","author":"Eisenach","year":"2010","journal-title":"Anesthesiology"},{"key":"R80-12-20210126","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/ALN.0b013e3181d94d8b","article-title":"Effects of intrathecal ketorolac on human experimental pain.","volume":"112","author":"Eisenach","year":"2010","journal-title":"Anesthesiology"},{"key":"R85-12-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1211\/jpp.62.01.0002","article-title":"Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety.","volume":"62","author":"El-Setouhy","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"R90-12-20210126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11739-009-0273-0","article-title":"Future drugs for migraine.","volume":"4","author":"Farinelli","year":"2009","journal-title":"Intern Emerg Med"},{"key":"R95-12-20210126","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.0869-05.2005","article-title":"The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus.","volume":"25","author":"Fischer","year":"2005","journal-title":"J Neurosci"},{"key":"R100-12-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/j.1552-4604.1996.tb05041.x","article-title":"New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers.","volume":"36","author":"Geisslinger","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"R105-12-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2006.12.056","article-title":"The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study.","volume":"414","author":"Gu","year":"2007","journal-title":"Neurosci Lett"},{"key":"R110-12-20210126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000542-199901000-00022","article-title":"Spinal action of ketorolac, S()- and R()-ibuprofen on non-noxious activation of the catechol oxidation in the rat locus coeruleus: evidence for a central role of prostaglandins in the strychnine model of allodynia.","volume":"90","author":"Hall","year":"1999","journal-title":"Anesthesiology"},{"key":"R115-12-20210126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-6-10","article-title":"Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.","volume":"6","author":"Han","year":"2010","journal-title":"Mol Pain"},{"key":"R120-12-20210126","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1523\/JNEUROSCI.4112-05.2005","article-title":"Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior.","volume":"25","author":"Han","year":"2005","journal-title":"J Neurosci"},{"key":"R125-12-20210126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjp.0704844","article-title":"A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells.","volume":"137","author":"Hay","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R130-12-20210126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1527-3466.2005.tb00155.x","article-title":"The preclinical pharmacology of BIBN4096BS, a CGRP antagonist.","volume":"23","author":"Hay","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"key":"R135-12-20210126","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation.","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"R140-12-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.regpep.2004.10.010","article-title":"Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay.","volume":"127","author":"Hershey","year":"2005","journal-title":"Regul Pept"},{"key":"R145-12-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2009.11.035","article-title":"Blockade effects of BIBN4096BS on CGRP-induced inhibition on whole-cell K currents in spinal dorsal horn neuron of rats.","volume":"469","author":"Hou","year":"2010","journal-title":"Neurosci Lett"},{"key":"R150-12-20210126","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pain.2009.02.018","article-title":"Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833.","volume":"143","author":"Hu","year":"2009","journal-title":"PAIN"},{"key":"R155-12-20210126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1744-8069-8-66","article-title":"Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura.","volume":"8","author":"Huang","year":"2012","journal-title":"Mol Pain"},{"key":"R160-12-20210126","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbi.2011.02.007","article-title":"Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells.","volume":"25","author":"Huang","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R165-12-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(86)90423-3","article-title":"Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains.","volume":"374","author":"Inagaki","year":"1986","journal-title":"Brain Res"},{"key":"R170-12-20210126","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-2982.2004.00726.x","article-title":"Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers.","volume":"24","author":"Iovino","year":"2004","journal-title":"Cephalalgia"},{"key":"R175-12-20210126","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2005.02.012","article-title":"The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes.","volume":"381","author":"Just","year":"2005","journal-title":"Neurosci Lett"},{"key":"R180-12-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(97)00108-5","article-title":"Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin.","volume":"73","author":"Kilo","year":"1997","journal-title":"PAIN"},{"key":"R185-12-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2005.01.002","article-title":"Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.","volume":"293","author":"Kim","year":"2005","journal-title":"Int J Pharm"},{"key":"R190-12-20210126","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1468-2982.2008.01745.x","article-title":"Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus.","volume":"29","author":"Koulchitsky","year":"2009","journal-title":"Cephalalgia"},{"key":"R195-12-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2009.03.022","article-title":"The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice.","volume":"51","author":"Kroeger","year":"2009","journal-title":"J Hepatol"},{"key":"R200-12-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(88)90395-2","article-title":"Calcitonin gene-related peptide (CGRP) in the rat central nervous system: patterns of immunoreactivity and receptor binding sites.","volume":"463","author":"Kruger","year":"1988","journal-title":"Brain Res"},{"key":"R205-12-20210126","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1213\/01.ane.0000229716.39977.fa","article-title":"The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia.","volume":"103","author":"Kumar","year":"2006","journal-title":"Anesth Analg"},{"key":"R210-12-20210126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejpain.2010.11.018","article-title":"Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury.","volume":"15","author":"Lee","year":"2011","journal-title":"Eur J Pain"},{"key":"R215-12-20210126","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.","volume":"507","author":"Lennerz","year":"2008","journal-title":"J Comp Neurol"},{"key":"R220-12-20210126","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-4632.2011.05197.x","article-title":"A comparison of neuropeptide expression in skin with allergic contact dermatitis in human and mouse.","volume":"51","author":"Lim","year":"2012","journal-title":"Int J Dermatol"},{"key":"R225-12-20210126","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/00001756-200310270-00007","article-title":"The pattern and distribution of calcitonin gene-related peptide (CGRP) terminals in the rat dorsal following neonatal peripheral inflammation.","volume":"14","author":"Ling","year":"2003","journal-title":"Neuroreport"},{"key":"R230-12-20210126","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1523\/JNEUROSCI.6345-11.2012","article-title":"Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway.","volume":"32","author":"Little","year":"2012","journal-title":"J Neurosci"},{"key":"R235-12-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.2010.06927.x","article-title":"Chronic prostaglandin E2 treatment induces the synthesis of the pain-related peptide substance P and calcitonin gene-related peptide in cultured sensory ganglion explants.","volume":"115","author":"Ma","year":"2010","journal-title":"J Neurochem"},{"key":"R240-12-20210126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2004.05.007","article-title":"Involvement of substance P, CGRP and histamine in the hyperalgesia and cytokine upregulation induced by intraplantar injection of capsaicin in rats.","volume":"153","author":"Massaad","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R245-12-20210126","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1526-4610.2012.02212.x","article-title":"CGRP and NO in the trigeminal system: mechanisms and role in headache generation.","volume":"52","author":"Messlinger","year":"2012","journal-title":"Headache"},{"key":"R250-12-20210126","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.0503264102","article-title":"Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene.","volume":"102","author":"Mogil","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R255-12-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-010-0105-6","article-title":"Acute migraine therapy: new drugs and new approaches.","volume":"13","author":"Monteith","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"R260-12-20210126","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbi.2010.06.008","article-title":"Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.","volume":"24","author":"Mousa","year":"2010","journal-title":"Brain Behav Immun"},{"key":"R265-12-20210126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AJP.0b013e3181817add","article-title":"Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft.","volume":"25","author":"Nader","year":"2009","journal-title":"Clin J Pain"},{"key":"R270-12-20210126","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1152\/jn.00799.2002","article-title":"Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain.","volume":"89","author":"Neugebauer","year":"2003","journal-title":"J Neurophysiol"},{"key":"R275-12-20210126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1523\/JNEUROSCI.23-01-00052.2003","article-title":"Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5.","volume":"23","author":"Neugebauer","year":"2003","journal-title":"J Neurosci"},{"key":"R375-12-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.npep.2012.07.008","article-title":"Effects of calcitonin gene-related peptide on the immune privilege of human hair follicles.","volume":"47","author":"Pi","year":"2013","journal-title":"Neuropeptide"},{"key":"R285-12-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WCO.0b013e32832b2427","article-title":"Calcitonin gene-related peptide: an update on the biology.","volume":"22","author":"Recober","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"R290-12-20210126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pain.2008.05.003","article-title":"Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin.","volume":"139","author":"Roeska","year":"2008","journal-title":"PAIN"},{"key":"R295-12-20210126","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1021\/jm0490641","article-title":"Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-N2-3,5-dibromo-N-4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidi nylcarbonyl-d-tyrosyl-l-lysyl-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.","volume":"48","author":"Rudolf","year":"2005","journal-title":"J Med Chem"},{"key":"R300-12-20210126","doi-asserted-by":"crossref","first-page":"41595","DOI":"10.1074\/jbc.M112.381368","article-title":"Ligand directed signaling differences between rodent and human kappa opioid receptors.","volume":"287","author":"Schattauer","year":"2012","journal-title":"J Biol Chem"},{"key":"R305-12-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-2999(02)01544-3","article-title":"Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, (3)HBIBN4096BS.","volume":"442","author":"Schindler","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R310-12-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(85)91116-3","article-title":"Binding sites for calcitonin gene-related peptide in distinct areas of rat brain.","volume":"346","author":"Seifert","year":"1985","journal-title":"Brain Res"},{"key":"R315-12-20210126","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1139\/y95-141","article-title":"Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation.","volume":"73","author":"Seybold","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"R320-12-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(03)00008-3","article-title":"The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin.","volume":"104","author":"Sun","year":"2003","journal-title":"PAIN"},{"key":"R325-12-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejps.2004.03.018","article-title":"Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonists.","volume":"22","author":"Troconiz","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"R330-12-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2007.01.058","article-title":"The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.","volume":"562","author":"Troltzsch","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R335-12-20210126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1073\/pnas.82.1.248","article-title":"Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary.","volume":"82","author":"Tschopp","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R340-12-20210126","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3129\/i10-048","article-title":"Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial.","volume":"45","author":"Unlu","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"R345-12-20210126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2009.11.011","article-title":"Topical and systemic administrations of ketanserin attenuate hypersensitivity and expression of CGRP in rats with spinal nerve ligation.","volume":"627","author":"Wang","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R350-12-20210126","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1042\/bst0300468","article-title":"Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.","volume":"30","author":"Wu","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"R355-12-20210126","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/07357909809011705","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs.","volume":"16","author":"Yaksh","year":"1998","journal-title":"Cancer Invest"},{"key":"R360-12-20210126","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/toxsci\/kfh168","article-title":"Intrathecal ketorolac in dogs and rats.","volume":"80","author":"Yaksh","year":"2004","journal-title":"Toxicol Sci"},{"key":"R365-12-20210126","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(99)00088-3","article-title":"Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord.","volume":"92","author":"Ye","year":"1999","journal-title":"Neuroscience"},{"key":"R370-12-20210126","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-7634(96)00023-1","article-title":"Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors.","volume":"21","author":"Van Rossum","year":"1997","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006396-201305000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T20:08:28Z","timestamp":1644091708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006396-201305000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2013.01.002","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}